Bharat Book Bureau Provides the Trending Market Research Report on “In-Vitro Diagnostics Market by Offering, Technology, Application, Diagnostic Approach — Global Forecast to 2030”under Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports. In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC)—Global Forecast to 2030 The global in vitro diagnostics market is expected to register a CAGR of 4.6% from 2023 to 2030 to reach $130.1 billion by 2030. The growth of the global in vitro diagnostics market is mainly attributed to the rising prevalence of chronic diseases coupled with the increasing geriatric population, rising prevalence of acute and chronic infectious diseases, increasing funding for research activities, growing awareness regarding early disease diagnosis, growing demand for point-of-care (POC) diagnostics and rapid diagnosis, rising healthcare expenditure, and increasing funding for research activities. Moreover, the inclination of emerging economies toward personalized medicine and advancements in genomics & proteomics offer significant growth opportunities for the players operating in this market. Based on offering, the reagents & kits segment is expected to grow with the fastest growth during the forecast period owing to its advantages as it can detect several markers simultaneously, which is useful for detecting complex diseases. Its technological superiority and the ability to facilitate chemical reactions further support the growth of this segment. Based on the technology, in 2023, the molecular diagnostics segment is expected to account for the largest share of the market. The largest share of the segment attributed to its improved specificity, cost-savings and enhanced throughput when automated, minimizing the false positive test results by targeting specific molecules, as well as improved diagnosis of infections such as orthopedic infections. Based on diagnostic approach, the laboratory testing segment is expected to account for the largest share of the market. Lab testing is a traditional approach in which the clinician takes a sample from the patient and sends it to the laboratory for processing and testing. Factors such as low costs of tests, highly sensitive analyzers, more accuracy and reliability, and accessibility & availability of multiple IVD tests support the largest share of the segment. Based on application, in 2023, the infectious diseases segment is expected to account for the largest share of the global in vitro diagnostics (IVD) market owing to the high prevalence of infectious diseases, government initiatives to promote awareness and testing, and emerging outbreaks of infectious diseases around the world. Based on end user, the hospitals & clinics segment is expected to grow with the highest CAGR during the forecast period. Patient inflows at hospitals & clinics and subsequent increase in the volume of testing carried out in hospitals and clinics due to the outbreak of COVID-19 support the growth of this segment. An in-depth analysis of the geographical scenario of the global in-vitro diagnostics (IVD) market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the IVD market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The high prevalence of chronic and infectious diseases, high awareness regarding early disease diagnosis, high adoption of advanced diagnostic products, and presence of funding coupled with novel developments in diagnostic technologies support the large share of this market. The key players operating in the global in-vitro diagnostics market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Wama Diagnostica (Brazil), Wiener Laboratorios SAIC (Argentina), QuidelOrtho Corporation (U.S.), Agilent Technologies Inc. (U.S.), and DiaSorin S.p.A. (Italy). Scope of the Report: Global In Vitro Diagnostics Market Assessment—by Offering •Reagents & Kits •Instruments •Software & Services Global In Vitro Diagnostics Market Assessment—by Technology •Molecular Diagnostics §Polymerase Chain Reaction (PCR) §Hybridization §Isothermal Nucleic Acid Amplification Technology §DNA Sequencing & Next-generation Sequencing §Microarrays §Mass Spectrometry §Other Molecular Diagnostic Technologies (Other Molecular Diagnostic Technologies majorly include electrophoresis, Ligase Chain Reaction (LCR), Northern Blot, and Southern Blot) •Point of Care (POC) Diagnostics §Lateral Flow Assays/Rapid Tests §POC Molecular Diagnostics §Other PoC Products •Immunoassay/Immunochemistry §Enzyme-linked Immunosorbent Assays (ELISA) §Enzyme-linked Immunospot Assays (ELISPOT) §Western Blotting §Radioimmunoassay •Biochemistry/Clinical Chemistry §Metabolic Panel §Electrolyte Panel §Liver Panel §Lipid Profile §Renal Profile §Thyroid Function Panel •Whole Blood Glucose Monitoring •Microbiology •Hematology •Coagulation/Hemostasis •Urinalysis •Other IVD Technologies (Other IVD technologies comprise anatomical pathology, histochemistry, and loop-mediated amplification). Global In Vitro Diagnostics Market Assessment—by Application •Infectious Diseases §COVID-19 Testing §Sexually Transmitted Diseases (STD) Testing §Healthcare-associated Infections (HAIs) §Hepatitis §HIV §Tropical Diseases §Respiratory Infections (Excluding Influenza) §Influenza §Other Infectious Diseases •Oncology •Diabetes •Cardiology •Nephrology •Autoimmune Disorders •Other Applications (Other applications comprise drugs of abuse tests, coagulation tests, neonatal testing, genetic testing, and neurological disorders testing). (Other infectious diseases include congenital infections, meningitis, norovirus (stomach flu), hand, foot, and mouth disease (HFMD), and pertussis). Global In Vitro Diagnostics Market Assessment—by Diagnostic Approach •Laboratory Testing •OTC/Self-testing •Point-of-Care Testing Global In Vitro Diagnostics Market Assessment—by End User •Diagnostic Laboratories •Hospitals & Clinics •Home Healthcare •Other End Users (Other end users comprise nursing homes, academic & research institutes, ambulatory care centers, and transfusion laboratories.) Global In vitro Diagnostics Market Assessment—by Geography •North America §U.S. §Canada •Europe §Germany §France §U.K. §Italy §Spain §Switzerland §Rest of Europe •Asia-Pacific §Japan §China §India §South Korea §Australia §Rest of Asia-Pacific •Latin America §Brazil §Mexico §Argentina §Rest of Latin America •Middle East §Saudi Arabia §Rest of Middle East •Africa §South Africa §Rest of Africa Browse our full report with Table of Content : https://www.bharatbook.com/report/1413599/in-vitro-diagnostics-market-by-offering-kits-software-technology-immunoassay-molecular-diagnostics-pcr-ngs-microarray-rapid-tests-biochemistry-application-infectious-diseases-oncology-diagnostic-approach-lab-pocglobal-forecast-to About Bharat Book Bureau: Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors. Contact us at: Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: poonam@bharatbook.com Website: www.bharatbook.com
